Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children

Kim D G van de Kant1, Ester M M Klaassen, Koen J van Aerde

  • 1Department of Paediatric Pulmonology, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC), PO Box 5800, 6202 AZ, Maastricht, The Netherlands. kim.vande.kant@mumc.nl

Journal of Breath Research
|September 20, 2012
PubMed

Insights

Preschool wheeze is linked to increased airway inflammation, indicated by elevated exhaled inflammatory markers. Bacterial presence and regulatory T cells did not significantly differ between wheezing and non-wheezing children, suggesting no bacterial link to inflammation.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Microbiology

Background:

  • Recurrent wheeze is common in preschoolers, but the roles of bacteria, regulatory T cells, and airway inflammation are not well understood.
  • Understanding these factors is crucial for early diagnosis and management of pediatric respiratory conditions.

Purpose of the Study:

  • To investigate the association between airway inflammation markers in exhaled breath condensate (EBC), bacterial colonization, and regulatory T cells in preschool children with recurrent wheeze.
  • To determine if bacterial presence influences airway inflammation or regulatory T cell proportions in wheezing children.

Main Methods:

  • Recruited 252 preschool children (2-4 years), with 202 experiencing recurrent wheeze and 50 serving as controls.
  • Assessed inflammatory markers (IL-2, IL-4, IL-8, IL-10, IL-13) in EBC using multiplex immunoassay.
  • Analyzed nasal/throat swabs for bacteria (Streptococcus pneumoniae, Haemophilus (para)influenzae, Staphylococcus aureus) and quantified regulatory T cells via flow cytometry.

Main Results:

  • Children with recurrent wheeze showed significantly elevated EBC levels of IL-2, IL-4, IL-10, and IL-13 compared to non-wheezers.
  • Bacterial colonization and regulatory T cell proportions did not differ significantly between wheezing and non-wheezing groups.
  • No significant differences in inflammatory markers or T cell proportions were observed between wheezing children with or without bacterial colonization.

Conclusions:

  • Elevated exhaled inflammatory markers in EBC suggest increased airway inflammation in preschool children with recurrent wheeze.
  • Exhaled breath condensate analysis is a promising non-invasive tool for assessing airway inflammation in young children.
  • Current findings do not support a role for bacterial-induced airway inflammation in preschool wheeze.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...